Pharmaceutical Information |
Drug Name |
Hydroxyprogesterone |
Drug ID |
BADD_D01106 |
Description |
Not Available |
Indications and Usage |
Hydroxyprogesterone caproate is indicated for the prevention of spontaneous preterm births in singleton pregnancies in women who have previously had a spontaneous preterm birth. (1) |
Marketing Status |
Not Available |
ATC Code |
G03DA03 |
DrugBank ID |
DB14570
|
KEGG ID |
D08052
|
MeSH ID |
D000077713
|
PubChem ID |
6238
|
TTD Drug ID |
D00AEQ
|
NDC Product Code |
73309-243 |
Synonyms |
17 alpha-Hydroxyprogesterone Caproate | 17 alpha Hydroxyprogesterone Caproate | 17-alpha-Hydroxy-Progesterone Caproate | 17 alpha Hydroxy Progesterone Caproate | Caproate, 17-alpha-Hydroxy-Progesterone | Oxyprogesterone Caproate | Hydroxyprogesterone Caproate | Hydroxyprogesterone Hexanoate | 17 alpha-Oxyprogesterone Capronate | 17 alpha Oxyprogesterone Capronate | 17-Hydroxyprogesterone Capronate | 17 Hydroxyprogesterone Capronate | Prolutin Depot | Proluton Depot | Neolutin | Makena | Delalutin |
|
Chemical Information |
Molecular Formula |
C21H30O3 |
CAS Registry Number |
68-96-2 |
SMILES |
CC(=O)C1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|